22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands
November 16, 2022 09:25 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 16, 2022 (GLOBE NEWSWIRE) -- GVB Biopharma, a 22nd Century Group company (Nasdaq: XXII), today announced that it has opened a new, strategically-located distribution facility in...
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022
August 09, 2022 06:00 ET
|
22nd Century Group, Inc
Strong Chicago Pilot Exceeded Expectations, Accelerates VLN® Expansion in ColoradoAccretive GVB Biopharma Acquisition Doubles Corporate Revenue and Expands Market Leading Hemp/Cannabis...
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
May 18, 2022 16:30 ET
|
22nd Century Group, Inc
Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMOConsistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for...